UK markets close in 2 hours 8 minutes

  • FTSE 100

    6,542.89
    -109.07 (-1.64%)
     

  • FTSE 250

    21,037.70
    -160.42 (-0.76%)
     

  • AIM

    1,182.60
    -9.26 (-0.78%)
     

  • GBP/EUR

    1.1521
    +0.0023 (+0.20%)
     

  • GBP/USD

    1.3973
    -0.0040 (-0.28%)
     

  • BTC-GBP

    33,140.74
    -3,941.17 (-10.63%)
     

  • CMC Crypto 200

    925.95
    -7.19 (-0.77%)
     

  • S&P 500

    3,829.34
    -96.09 (-2.45%)
     

  • DOW

    31,402.01
    -559.85 (-1.75%)
     

  • CRUDE OIL

    62.49
    -1.04 (-1.64%)
     

  • GOLD FUTURES

    1,759.40
    -16.00 (-0.90%)
     

  • NIKKEI 225

    28,966.01
    -1,202.26 (-3.99%)
     

  • HANG SENG

    28,980.21
    -1,093.96 (-3.64%)
     

  • DAX

    13,826.94
    -52.39 (-0.38%)
     

  • CAC 40

    5,732.12
    -51.77 (-0.90%)
     
Budget 2021:

Targeted tax rises won't derail COVID recovery, chancellor told

Corporation tax, capital gains tax, wealth tax, and land value tax rises would make a 'negligible impact' on GDP growth

European stocks fall on Covid-19 concerns

Yahoo Finance's Tom Belger has the latest from London.

Latest stories

  • Notification of Major Holdings

    TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:G4S plc1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate)Non-UK issuer 2. Reason for the notification (please mark the appropriate box or boxes with an “X”)An acquisition or disposal of voting rightsXAn acquisition or disposal of financial instrumentsXAn event changing the breakdown of voting rights Other (please specify)iii: 3. Details of person subject to the notification obligationivNameThe Goldman Sachs Group, Inc.City and country of registered office (if applicable)Corporation Trust Center, 1209 Orange Street, Wilmington DE 19801, USA4. Full name of shareholder(s) (if different from 3.)vNameGoldman Sachs InternationalCity and country of registered office (if applicable)Plumtree Court, 25 Shoe Lane, London EC4A 4AU,UK5. Date on which the threshold was crossed or reachedvi:23/02/20216. Date on which issuer notified (DD/MM/YYYY):25/02/20217. Total positions of person(s) subject to the notification obligation % of voting rights attached to shares (total of 8. A)% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)Total of both in % (8.A + 8.B)Total number of voting rights held in issuerviiResulting situation on the date on which threshold was crossed or reached0.03%5.78%5.81%1,551,594,436Position of previous notification (if applicable)0.03%6.86%6.89% 8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviiiA: Voting rights attached to sharesClass/type of sharesISIN code (if possible)Number of voting rightsix% of voting rightsDirect(DTR5.1)Indirect (DTR5.2.1)Direct(DTR5.1)Indirect(DTR5.2.1)GB00B01FLG62 450,866 0.03%US37441W1080 21,105 0.001% SUBTOTAL 8. A471,9710.03% B 1: Financial Instruments according to DTR5.3.1R (1) (a)Type of financial instrumentExpiration datexExercise/ Conversion PeriodxiNumber of voting rights that may be acquired if the instrument is exercised/converted.% of voting rightsSecurities LendingOpen 88,610,7045.71% SUBTOTAL 8. B 188,610,7045.71% B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)Type of financial instrumentExpiration datexExercise/ Conversion Period xiPhysical or cash settlementxiiNumber of voting rights % of voting rightsCFD24/02/2031 Cash 392,192 0.03%CFD16/09/2030 Cash 376,107 0.02%CFD27/03/2023 Cash 146,537 0.01%CFD30/09/2025 Cash 88,028 0.01%CFD14/10/2021 Cash 31,066 0.002%CFD09/10/2025 Cash 3,957 0.0003%CFD14/07/2025 Cash 2,365 0.0002%Swap18/05/2021 Cash 150 0.00001% SUBTOTAL 8.B.21,040,4020.07% 9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an “X”)Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)XNamexv% of voting rights if it equals or is higher than the notifiable threshold% of voting rights through financial instruments if it equals or is higher than the notifiable thresholdTotal of both if it equals or is higher than the notifiable thresholdThe Goldman Sachs Group, Inc. Goldman Sachs (UK) L.L.C. Goldman Sachs Group UK Limited Goldman SachsInternational 5.78%5.78% The Goldman Sachs Group, Inc. Goldman Sachs & Co. LLC The Goldman Sachs Group, Inc. GSAM Holdings LLC Goldman Sachs Asset Management, L.P. The Goldman Sachs Group, Inc. IMD Holdings LLC United Capital Financial Partners, Inc. United Capital Financial Advisers, LLC 10. In case of proxy voting, please identify:Name of the proxy holderN/AThe number and % of voting rights heldN/AThe date until which the voting rights will be heldN/A 11. Additional informationxviPlease note, the total amount of voting rights have been rounded to 2 decimal places therefore there is a possibility of a rounding error. Place of completionLondonDate of completion25/02/2021

  • Europe Piroctone Olamine Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Type ; Application, and Country

    The Europe piroctone olamine market was valued at US$ 14,648. 22 Thousand in 2019 and is projected to reach US$ 20,058. 90 Thousand by 2027; it is expected to grow at a CAGR of 4. 1% from 2020 - 2027.New York, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Europe Piroctone Olamine Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Type ; Application, and Country" - https://www.reportlinker.com/p06004170/?utm_source=GNW Piroctone olamine, an ethanolamine salt of hydroxamic acid derivative named piroctone, is an antifungal agent.It is frequently used in anti-dandruff shampoos as a replacement for the compound zinc pyrithione.Piroctone olamine, when used in combination with other substances in shampoos, effectively reduced the dandruff levels and simultaneously provided hair conditioning.The fungus Malassezia globosa is responsible for causing dandruff and seborrheic dermatitis.The presence of this fungus results in scalp irritation and scalp starts shedding tiny flakes.In severe cases, inflammation, redness, and extremely itchy patches can occur.The anti-fungal properties of piroctone olamine aid in controlling the spread of Malassezia globosa. In addition to this, piroctone olamine also helps make hair smooth and silky, prevents hair fall, and boosts the hair growth.On the basis of application, the Europe piroctone olamine market is segmented into shampoo and hair care products, cosmetics, washing products.The shampoo and hair care products segment led the piroctone olamine market with the largest share in 2019.Piroctone olamine penetrates the cell membrane of the fungi Malassezia globosa to interfere with their energy metabolism and oxygen uptake.This kills the fungi and clears up the infection, thereby lowering the dandruff, which otherwise causes hair loss and thinning.The compound is often compared to ketoconazole, which is a widely used ingredient in anti-dandruff products.However, piroctone olamine offers better results against dandruff and fungal infections.Furthermore, with evolving customer requirements for shampoo products, manufacturers are continuously investing in innovation and are using beneficial products such as piroctone olamine to attain a competitive edge. The beauty and personal care industry is witnessing tremendous growth in various regions, mainly due to the increasing number of beauty-conscious consumers.The Europe piroctone olamine market is further segmented into Germany, France, Italy, the UK, Russia, and Rest of Europe; the Rest of Europe includes the Netherlands, Belgium, Spain, Hungary, Austria, Greece, Denmark, Belgium, Turkey, Czech Republic, Norway, and Romania.These countries have registered remarkable growth in the production and application of piroctone olamine.Furthermore, the demand for piroctone olamines in the rest of Europe is likely to rise during the forecast period due to growing investment in new product development by manufacturers. Many of the European countries have developed economies, which provide high spending power to consumers.Spec Chem Industry Inc.; Starchem Enterprises Limited; Zhonglan Industry Co., Ltd; Clariant; Merck KGaA; and JSN Chemicals LTD are among the major players in the Europe piroctone olamine market.The overall Europe piroctone olamine market size has been derived in accordance with both primary and secondary sources.To begin the research process, exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the market.Also, multiple primary interviews have been conducted with industry participants and commentators to validate the data, as well as to gain more analytical insights into the topic. The participants of this process include industry expert such as VPs, business development managers, market intelligence managers, and national sales managers, along with external consultants such as valuation experts, research analysts, and key opinion leaders, specializing in the piroctone olamine market.Read the full report: https://www.reportlinker.com/p06004170/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

  • The sooner Huawei can go back to using Google OS the better: USA chief security officer

    Chief Security Officer of Huawei USA Andy Purdy said the company is still hoping for a reunion with Google’s Android operating system.

  • AstraZeneca-Amgen drug could widen treatment options for severe asthma

    AstraZeneca and Amgen's experimental drug reduced asthma attacks in patients with severe and uncontrolled forms of the respiratory condition in a large study, showing promise for wider use against different triggers. The medicine, tezepelumab, cut the rate of asthma attacks by 56% among patients when compared to placebo in a year-long late-stage study, which had roughly 1,000 patients who were already receiving standard care, the drugmakers said on Friday. It also worked in a subgroup of volunteers with low levels of eosinophils, a type of white blood cell, detailed data presented at a virtual meeting of the American Academy of Allergy Asthma and Immunology showed.

  • INVESTIGATION REMINDER: The Schall Law Firm Announces It Is Investigating Claims Against Workhorse Group Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm

    INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Workhorse Group Inc.

  • Leeds v Aston Villa: match preview

    Leeds v Aston Villa: match preview

  • Anti-HS2 tunnel protest at Euston ends as final activist leaves

    Anti-HS2 tunnel protest at Euston ends as final activist leaves. Subterranean protest against high-speed rail line lasted 31 days in tunnel near London station

  • 'The first rule of a happy life,’ according to 97-year-old Charlie Munger

    “A happy life is very simple,” the 97-year-old Munger said during the Annual Meeting of Shareholders of the Daily Journal Corporation.

  • 'I take music seriously': Drag Race stars begin crossover chart success

    'I take music seriously': Drag Race stars begin crossover chart success. The Eurovision homage UK Hun has entered the charts ahead of Rita Ora and Pink, and leads a new wave of drag queens sashaying away from novelty pop

  • Europe Medical Plastic Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Type and Application

    The Europe medical plastic market was valued at US$ 6,434. 3 million in 2019 and is projected to reach US$ 11,792. 8 million by 2027; it is expected to grow at a CAGR of 7. 9% during the forecast period of 2020-2027.New York, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Europe Medical Plastic Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Type and Application" - https://www.reportlinker.com/p06004167/?utm_source=GNW Medical plastics are made from a huge number of macromolecules, which are utilized to produce consistent and safe instruments in the healthcare industry.They are remarkably long-lasting, supple, and economical.The performance, sterility, and quality of these tools is a major factor for market expansion.Medical plastics find a broad range of applications in diagnostic instruments, implants, disposables, drug delivery devices, surgical instruments, syringes, and catheters.The global population is projected to increase in the coming years.With the increasing population, diseases and infections are rampantly overspreading through several mediums.The rising geriatric population further enhances the development of the healthcare sector. Moreover, medical plastics are also exploited in prosthetics, and it offers a life-changing solution for physically disabled people.Based on type, the medical plastic market is segmented into standard plastics, engineering, plastics, high performance plastic (HPP), silicone, and others.In 2019, the standard plastic segment dominated the Europe medical plastic market.Based on application, the Europe medical plastic market is segmented into medical disposables, prosthetics, medical instruments and tools, drug delivery, and others. In 2019, the medical instruments and tools segment accounted for the largest share in the Europe medical plastic market.Geographically, the Europe medical plastic market is segmented into Germany, Italy, Russia, France, the UK, and Rest of Europe.Germany accounted for the largest share of the Europe medical plastic market.Germany is heavily contributing to this market since it is known as the manufacturing hub.The production and innovation of medical plastic applications have consistently risen for a decade.A recent study showed that innovation in drug delivery has been accelerating across Europe, especially in Germany.The research has successfully proved that there has been an average innovation increase of 4% in Germany.Increasing demand from drug delivery applications coupled with other applications—such as medical disposables, prosthetics, and medical instruments and tools—has further fuelled the growth of the market.Celanese Corporation, Eastman chemical company, GW Plastics, Orthoplastics Limited, Aran Biomedical, Rochling, SABIC, Saint-Gobain, Solvay, and Dow are among major players present in the Europe medical plastic market.Overall size of the Europe medical plastic market has been derived in accordance to primary and secondary sources.To begin the research process, exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the market.Also, multiple primary interviews have been conducted with industry participants and commentators to validate the data, as well as to gain more analytical insights into the topic. The participants who take part in such a process include industry experts, such as VPs, business development managers, market intelligence managers, and national sales managers, along with external consultants, such as valuation experts, research analysts, and key opinion leaders specializing in the Europe medical plastic market.Impact of COVID-19 Pandemic on Medical Plastic MarketIn Europe, Italy is the hardest-hit country by the COVID-19 outbreak.It is expected to suffer an economic hit due to a lack of revenue from various industries, as Italy recorded the highest number of COVID-19 cases.Other member states have implemented drastic measures and travel restrictions, including partially closing their borders. This is anticipated to impact the market growth in Europe.Read the full report: https://www.reportlinker.com/p06004167/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

  • Better Buy: Shopify vs. Zoom Video Communications

    Not surprisingly, Shopify (NYSE: SHOP) and Zoom Video Communications (NASDAQ: ZM) benefited greatly from these secular shifts and made many investors much wealthier in the process. In fact, share prices of Shopify soared 160%, and Zoom stock surged 288% over the last year. Shopify's digital commerce platform supports over 1.7 million global merchants, helping them create and manage online shops across different channels.

  • Terreno Realty Corporation Acquires Property in Kirkland, WA for $33.8 Million

    Terreno Realty Corporation Acquires Property in Kirkland, WA for $33.8 Million

  • EARNEST Partners Appoints Yugeng Sun and Aaron Kirchoff to Directors

    Earnest Partners Appoints Yugeng Sun and Aaron Kirchoff to Directors

  • Vehicle-carrier ship hit by explosion in Gulf of Oman

    A Bahamas-flagged ship, the MV HELIOS RAY, was hit by an explosion in the Gulf of Oman on Thursday, the United Kingdom Maritime Trade Operations (UKMTO) and a maritime security firm said on Friday. Maritime security firm Dryad Global said the MV HELIOS RAY was a vehicle carrier owned by Helios Ray Ltd, an Israeli firm registered in the Isle of Man. The ship was en route to Singapore from Dammam in Saudi Arabia. Israel's Transportation Ministry said it was not aware of the incident.

  • Rethink Education to Invest $5mm in Seed Stage, Underrepresented Founders Improving Learning Outcomes and Economic Mobility

    Rethink Education has earmarked $5mm to invest in underrepresented founders of color helping solve challenges from education to workforce development.

  • Global Radiosurgery and Radiotherapy Robotics (X-ray-Based & Gamma-ray-Based) Market 2021-2025 - ResearchAndMarkets.com

    The "Global Radiosurgery and Radiotherapy Robotics Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.

  • Absolutely everything you need to know about Cancers

    Their personality traits, what they're into and which star signs they get on best with.

  • Most Brits in favour of stamp duty holiday extension

    The stamp duty holiday, which is due to come to an end of March could be extended for another three months to 30 June this year.

  • Replacing a BMW M3 for $20,000: Window Shop with Car and Driver

    Special guest Zack Klapman of the Smoking Tire joins us to see if we can replace his E46 BMW M3.

  • Insights on the Dicamba Herbicide Global Market to 2027 - Featuring Alligare, BASF and Bayer CropScience Among Others

    Dublin, Feb. 26, 2021 (GLOBE NEWSWIRE) -- The "Dicamba Herbicide - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. The publisher brings years of research experience to the 9th edition of this report. The 283-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.Global Dicamba Herbicide Market to Reach $626.5 Million by 2027Amid the COVID-19 crisis, the global market for Dicamba Herbicide estimated at US$413.5 Million in the year 2020, is projected to reach a revised size of US$626.5 Million by 2027, growing at a CAGR of 6.1% over the analysis period 2020-2027. Cereals & Grains, one of the segments analyzed in the report, is projected to record a 6.6% CAGR and reach US$217.7 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Oilseeds & Pulses segment is readjusted to a revised 6.6% CAGR for the next 7-year period.The U.S. Market is Estimated at $111.9 Million, While China is Forecast to Grow at 9.3% CAGRThe Dicamba Herbicide market in the U.S. is estimated at US$111.9 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$134.1 Million by the year 2027 trailing a CAGR of 9.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.3% and 5.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.Pastures & Forage Crops Segment to Record 5.6% CAGRIn the global Pastures & Forage Crops segment, USA, Canada, Japan, China and Europe will drive the 5.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$58.7 Million in the year 2020 will reach a projected size of US$83.3 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$84.7 Million by the year 2027, while Latin America will expand at a 6.8% CAGR through the analysis period. Competitors identified in this market include, among others: Alligare LLCBASF SEBayer CropScience AGDowDuPont, Inc.Monsanto CompanyNufarm LimitedSyngenta AGThe Andersons, Inc. Key Topics Covered: I. INTRODUCTION, METHODOLOGY & REPORT SCOPEII. EXECUTIVE SUMMARY1. MARKET OVERVIEW Global Competitor Market SharesDicamba Herbicide Competitor Market Share Scenario Worldwide (in %): 2019 & 2025Impact of Covid-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS4. GLOBAL MARKET PERSPECTIVEIII. MARKET ANALYSISIV. COMPETITION Total Companies Profiled: 46 For more information about this report visit https://www.researchandmarkets.com/r/624cvu CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900